For example, in patients with rheumatoid arthritis and diabetes, anti-TNFα inhibitor therapy attenuated the patients’ insulin resistance and improved insulin sensitivity [67], also the risk for developing Alzheimer’s disease was reduced [67]. This evidence concerns the gene TNF and diabetes mellitus.